Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
Trial ID or NCT#
Status
Purpose
The purpose of the trial is to test the efficacy of combining conventional chemoradiotherapy with radiosurgery for locally advanced pancreas cancer.
Official Title
Phase II Study to Evaluate the Efficacy of Conventional Chemoradiotherapy Followed by Stereotactic Radiosurgery for Locally Advanced Pancreatic Cancer
Eligibility Criteria
- - Pancreatic tumors not to exceed 7.5 cm.
- * Histologically confirmed malignancies of the pancreas, (ampulla of Vater or periampullary duodenum, tumors may be included when the head of pancreas is secondarily involved and unresectable criteria are met).* Unresectable by CT criteria or unresectable at exploratory laparotomy or laparoscopy. CT criteria for unresectability include encasement of the superior mesenteric vein (SMV), portal vein (PV) or invasion of the celiac artery or superior mesenteric artery (SMA).* Patients with metastatic disease may be treated if they are symptomatic from the primary tumor.* Eastern Clinical Oncology Group performance status 0, 1 or 2.
- Chemotherapy within 1 month of registration.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Stanford Cancer Clinical Trials Office
6504987061
View on ClinicalTrials.gov